Form 4 for ENTA ENANTA PHARMACEUTICALS INC
Accepted 2023-02-13 00:00:00 ET · period of report 2023-02-09 · accession 0001062993-23-002936 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2023-02-13 | 2023-02-09 | ENTA | MELLETT PAUL J | CFO, Treas | S - Sale | $53.76 | -5,000 | 84.3K | -6% | -$268.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-02-09 | S | D | 800 | $54.41 | 83,463 | D | — | — | (F3) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $54.09 to $54.85, inclusive. |
| 2 | Common | Common Stock | 2023-02-09 | S | D | 4,200 | $53.64 | 84,263 | D | — | — | (F2) The price reported in Column 4 is a weighted-average price. These shares were sold in multiple transactions at prices ranging from $53.09 to $54.05, inclusive. |